Ramzi Salloum 
Associate Professor | University of Florida
Gainesville, FL, UNITED STATES
Ramzi Salloum works in health services research across diverse health systems and policy settings, with a focus on evidence-based programs.
Biography
Dr. Ramzi Salloum is an associate professor in the Department of Health Outcomes & Biomedical Informatics in the College of Medicine and the director of the Dissemination and Implementation Science Core at the UF Clinical and Translational Science Institute. Dr. Salloum is a member of the UF Health Cancer Center and the Institute for Child Health Policy. Dr. Salloum's research focuses on the implementation and dissemination of evidence-based practices, especially in cancer prevention and control. He has a demonstrated research record in the area of health services research across diverse health system and policy settings, with a particular focus on the implementation of evidence-based programs.
Areas of Expertise (3)
Global Health
Implementation Science
Tobacco Control
Articles (4)
Marijuana use among US adults with cancer: findings from the 2018-2019 Behavioral Risk Factor Surveillance System.
Journal of Cancer SurvivorshipMinjee Lee, et al.
2022-04-09
This study aimed to assess the prevalence of current marijuana use and to identify the factors associated with its use among US adults with cancer living in 17 US states and territories. Data from the 2018–2019 Behavioral Risk Factor Surveillance System Marijuana Use module were analyzed. The analytic sample included 13,174 adults with cancer. The primary outcome was current marijuana use.
How Smokers of Menthol Cigarettes and Flavored Cigars Might Respond to FDA's Proposed Bans
Nicotine & Tobacco ResearchYong Yang, et al.
2022-03-30
A ban on menthol cigarettes and flavored cigars may reduce smoking and tobacco-related disparities. We aimed to examine the response of current smokers to a hypothetical ban on menthol cigarettes and flavored cigars. Current smokers were recruited online and reported the alternative products that they may switch to under a hypothetical ban, if they would try to obtain the banned products from illicit channels and their support to the ban.
Feasibility of a primary care patient decision aid for smoking cessation with information about e-cigarettes
Preventive Medicine ReportsJennifer H. LeLaurin
2022-03-01
Decision aids can promote shared decision making and behavior change and may be effective in helping patients quit smoking. Patients are increasingly using e-cigarettes for smoking cessation; however, little is known about the impact of including e-cigarette information in smoking cessation decision aids. Our objective was to assess the feasibility and acceptability of a smoking cessation decision aid including e-cigarette information. This study was conducted at one family medicine clinic in the United States.
Expansion of Guideline-Recommended Lung Cancer Screening Eligibility: Implications for Health Equity of Joint Screening and Cessation Interventions
Journal of Thoracic OncologyRamzi G. Salloum, et al.
2022-01-01
Lung cancer remains the leading cause of death and the second most common cancer in the United States, largely because most patients have advanced, incurable disease at the time of diagnosis. Tobacco smoking continues to be the leading risk factor for lung cancer, accounting for an estimated 90% of all cases. In addition to smoking cessation, lung cancer screening with low-dose computed tomography (LDCT) has the potential to revolutionize lung cancer outcomes through early detection.
Social